USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Aug 8, 2022 | Jun 2022 | $-0.56 | - | $-0.56 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Aug 8, 2022 | Jun 2022 | $11.58M | - | $1.70M |
Chemocentryx, Inc's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 8 | $-0.56 | $-0.64 | $-0.39 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 8 | $-1.74 | $-2.44 | $-0.91 |
| Dec 2023 | 8 | $-0.63 | $-1.75 | $3.58 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 1 / 0 | $-0.57 | $-0.56 | $-0.54 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 2 / 0 | $-1.70 | $-1.79 | $-1.89 |
| Dec 2023 | 0 / 0 | $-0.24 | $-0.24 | $-0.22 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 8 | $11.58M | $7.41M | $23.78M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 7 | $87.35M | $39.00M | $153.48M |
| Dec 2023 | 8 | $211.36M | $79.00M | $580.52M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Apr 27, 2022 | Mar 2022 | $-0.19 | - | - |
| Mar 1, 2022 | Dec 2021 | $-0.58 | $-0.58 | - |
| Nov 9, 2021 | Sep 2021 | $-0.48 | $-0.32 | 33.75% |
| Aug 9, 2021 | Jun 2021 | $-0.54 | $-0.56 | -2.96% |
| Apr 29, 2021 | Mar 2021 | $-0.42 | $-0.43 | -2.50% |
| Mar 1, 2021 | Dec 2020 | $-0.33 | $-0.43 | -29.56% |
| Nov 9, 2020 | Sep 2020 | $-0.36 | $-0.35 | 1.60% |
| Aug 10, 2020 | Jun 2020 | $-0.34 | $0.29 | 186.13% |
| May 11, 2020 | Mar 2020 | $-0.30 | $-0.35 | -17.65% |
| Mar 10, 2020 | Dec 2019 | $-0.25 | $-0.26 | -4.42% |
| Nov 4, 2019 | Sep 2019 | $-0.26 | $-0.22 | 16.09% |
| Aug 5, 2019 | Jun 2019 | $-0.22 | $-0.26 | -17.12% |
| May 6, 2019 | Mar 2019 | $-0.26 | $-0.23 | 10.26% |
| Mar 11, 2019 | Dec 2018 | $-0.27 | $-0.21 | 21.58% |
| Nov 8, 2018 | Sep 2018 | $-0.25 | $-0.22 | 10.31% |
| Aug 9, 2018 | Jun 2018 | $-0.23 | $-0.14 | 39.89% |
| May 9, 2018 | Mar 2018 | $-0.24 | $-0.19 | 22.19% |
| Mar 9, 2018 | Dec 2017 | $-0.18 | $0.80 | 554.03% |
| Nov 7, 2017 | Sep 2017 | $-0.32 | $-0.13 | 58.76% |
| Aug 8, 2017 | Jun 2017 | $-0.17 | $-0.19 | -11.76% |
| May 10, 2017 | Mar 2017 | $-0.30 | $-0.12 | 60.00% |
| Mar 14, 2017 | Dec 2016 | $-0.22 | $-0.16 | 27.27% |
| Nov 7, 2016 | Sep 2016 | $-0.08 | $-0.15 | -87.50% |
| Aug 8, 2016 | Jun 2016 | $0.07 | $-0.22 | -414.29% |
| May 10, 2016 | Mar 2016 | $-0.27 | $-0.34 | -25.93% |
| Mar 14, 2016 | Dec 2015 | $-0.28 | $-0.26 | 8.58% |
| Nov 9, 2015 | Sep 2015 | $-0.28 | $-0.26 | 7.14% |
| Aug 6, 2015 | Jun 2015 | $-0.28 | $-0.28 | - |
| May 6, 2015 | Mar 2015 | $-0.28 | $-0.28 | - |
| Mar 12, 2015 | Dec 2014 | $-0.28 | $-0.28 | - |
| Nov 5, 2014 | Sep 2014 | $-0.28 | $-0.25 | 10.71% |
| Aug 5, 2014 | Jun 2014 | $-0.26 | $-0.28 | -7.69% |
| May 8, 2014 | Mar 2014 | $-0.24 | $-0.27 | -12.50% |
| Mar 13, 2014 | Dec 2013 | $-0.24 | $-0.22 | 8.33% |
| Nov 7, 2013 | Sep 2013 | $-0.26 | $-0.22 | 15.38% |
| Aug 12, 2013 | Jun 2013 | $-0.28 | $-0.23 | 17.86% |
| May 13, 2013 | Mar 2013 | $-0.26 | $-0.28 | -7.69% |
| Mar 13, 2013 | Dec 2012 | $-0.28 | $-0.28 | - |
| Nov 13, 2012 | Sep 2012 | $-0.22 | $-0.28 | -27.27% |
| Aug 10, 2012 | Jun 2012 | $-0.21 | $-0.30 | -42.86% |
| May 10, 2012 | Mar 2012 | $-0.21 | $-0.28 | -33.33% |
| Mar 30, 2012 | Dec 2011 | - | $4.33 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 1, 2022 | Dec 2021 | $-1.89 | $-1.89 | - |
| Mar 1, 2021 | Dec 2020 | $-0.74 | $-0.84 | - |
| Mar 10, 2020 | Dec 2019 | $-0.97 | $-0.97 | - |
| Mar 11, 2019 | Dec 2018 | $-0.83 | $-0.76 | - |
| Mar 9, 2018 | Dec 2017 | $-0.65 | $0.36 | - |
| Mar 14, 2017 | Dec 2016 | - | $-0.87 | - |
| Mar 14, 2016 | Dec 2015 | - | $-1.08 | - |
| Mar 12, 2015 | Dec 2014 | - | $-1.08 | - |
| Mar 13, 2014 | Dec 2013 | - | $-0.95 | - |
| Mar 13, 2013 | Dec 2012 | - | $-1.14 | - |
| Mar 30, 2012 | Dec 2011 | - | $4.33 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Apr 27, 2022 | Mar 2022 | $30.97M | - | - |
| Mar 1, 2022 | Dec 2021 | $4.22M | $2.61M | 0.62% |
| Nov 9, 2021 | Sep 2021 | $8.66M | $17.69M | 2.04% |
| Aug 9, 2021 | Jun 2021 | $1.81M | $1.70M | 0.94% |
| Apr 29, 2021 | Mar 2021 | $7.93M | $10.22M | 1.29% |
| Mar 1, 2021 | Dec 2020 | $7.99M | $4.36M | 0.55% |
| Nov 9, 2020 | Sep 2020 | $10.70M | $5.03M | 0.47% |
| Aug 10, 2020 | Jun 2020 | $8.25M | $49.28M | 5.97% |
| May 11, 2020 | Mar 2020 | $8.75M | $5.86M | 0.67% |
| Mar 10, 2020 | Dec 2019 | $9.68M | $9.87M | 1.02% |
| Nov 4, 2019 | Sep 2019 | $7.70M | $10.58M | 1.37% |
| Aug 5, 2019 | Jun 2019 | $9.83M | $7.17M | 0.73% |
| May 6, 2019 | Mar 2019 | $10.97M | $8.33M | 0.76% |
| Mar 11, 2019 | Dec 2018 | $9.41M | $9.33M | 0.99% |
| Nov 8, 2018 | Sep 2018 | $8.97M | $8.97M | 1.00% |
| Aug 9, 2018 | Jun 2018 | $14.06M | $15.02M | 1.07% |
| May 9, 2018 | Mar 2018 | $6.30M | $9.55M | 1.52% |
| Mar 9, 2018 | Dec 2017 | $9.40M | $56.30M | 5.99% |
| Nov 7, 2017 | Sep 2017 | $9.03M | $9.03M | 1.00% |
| Aug 8, 2017 | Jun 2017 | $8.94M | $8.94M | 1.00% |
| May 10, 2017 | Mar 2017 | - | $8.23M | - |
| Mar 14, 2017 | Dec 2016 | - | $4.68M | - |
| Nov 7, 2016 | Sep 2016 | - | $4.13M | - |
| Aug 8, 2016 | Jun 2016 | - | $2.62M | - |
| May 10, 2016 | Mar 2016 | - | $0.00 | - |
| Mar 14, 2016 | Dec 2015 | - | $0.00 | - |
| Nov 9, 2015 | Sep 2015 | - | $0.00 | - |
| Aug 6, 2015 | Jun 2015 | - | $0.00 | - |
| May 6, 2015 | Mar 2015 | - | $0.00 | - |
| Mar 12, 2015 | Dec 2014 | - | $0.00 | - |
| Nov 5, 2014 | Sep 2014 | - | $0.00 | - |
| Aug 5, 2014 | Jun 2014 | - | $0.00 | - |
| May 8, 2014 | Mar 2014 | - | $725.00K | - |
| Mar 13, 2014 | Dec 2013 | - | $725.00K | - |
| Nov 7, 2013 | Sep 2013 | - | $1.52M | - |
| Aug 12, 2013 | Jun 2013 | - | $1.89M | - |
| May 13, 2013 | Mar 2013 | - | $1.93M | - |
| Mar 13, 2013 | Dec 2012 | - | $2.15M | - |
| Nov 13, 2012 | Sep 2012 | - | $1.13M | - |
| Aug 10, 2012 | Jun 2012 | - | $1.13M | - |
| May 10, 2012 | Mar 2012 | - | $1.02M | - |
| Mar 30, 2012 | Dec 2011 | - | $26.05M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 1, 2022 | Dec 2021 | $33.24M | $32.22M | -3.06% |
| Mar 1, 2021 | Dec 2020 | $68.44M | $64.89M | -5.19% |
| Mar 10, 2020 | Dec 2019 | $35.74M | $35.95M | 0.59% |
| Mar 11, 2019 | Dec 2018 | $43.06M | $42.88M | -0.43% |
| Mar 9, 2018 | Dec 2017 | $35.53M | $82.50M | 132.19% |
| Mar 14, 2017 | Dec 2016 | - | $11.44M | - |
| Mar 14, 2016 | Dec 2015 | - | $0.00 | - |
| Mar 12, 2015 | Dec 2014 | - | $0.00 | - |
| Mar 13, 2014 | Dec 2013 | - | $6.06M | - |
| Mar 13, 2013 | Dec 2012 | - | $5.42M | - |
| Mar 30, 2012 | Dec 2011 | - | $31.67M | - |
CCXI's next earnings date is Monday, Aug 8, 2022 for the fiscal quarter ending Jun 30, 2022.
According to analysts, the average EPS estimation for Chemocentryx, Inc's next quarterly earnings is $-0.56, with a low EPS estimation of $-0.64, and a high estimation of $-0.39.
Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.57, the last 2 month trend is $-0.56, and the 3 month trend is $-0.54.
Based on analysts, the average revenue estimation is $11.58M, with a low revenue estimation of $7.41M, and a high estimation of $23.78M.
Chemocentryx, Inc's previous earnings date was Apr 27, 2022 for its fiscal quarter ended Mar 31, 2022.
Chemocentryx, Inc's previous annual earnings date was Mar 1, 2022 for its fiscal year ended Dec 31, 2021.
CCXI's earnings per share (EPS) was $-1.89, beating the consensus analysts forecast of $-1.89 by 0.00% , and lower than the previous year's EPS (Dec 2020) by 125.00%.
Revenues were $32.22M, worse than the forecast of $33.24M by -3.06%, and down by -50.34% from previous year's revenue.
The company reported a net income of $-131.75M.
Chemocentryx, Inc reported a free cash flow of $-94.64M for its fiscal year, compared to $-96.55M a year ago.
The company ended the fiscal year with $4.71M in total debt, a decrease of -81.32% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
